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Abstract Solubility data were measured for omeprazole sulfide in ethanol, 95 mass-%
ethanol, ethyl acetate, isopropanol, methanol, acetone, n-butanol and n-propanol in the
temperature range from 280.35 to 319.65 K by employing the gravimetric method. The
solubilities increase with temperature and they are in good agreement with the calculated
solubility of the modified Apelblat equation and the kh equation. The experimental solubility
and correlation equation in this work can be used as essential data and model in the puri-
fication process of omeprazole sulfide. The thermodynamic properties of the solution pro-
cess, including the Gibbs energy, enthalpy, and entropy were calculated using the van’t Hoff
equation.
Keywords Omeprazole sulfide  Solubility  Gravimetric method  Purification 
Solution thermodynamics
1 Introduction
Omeprazole sulfide, an amorphous colorless or white powder, is odorless and stable in air.
Omeprazole sulfide (C17H19N3O2S, FW 329.42, CAS Registry No. 73590-85-9, structure
shown in Fig. 1) is a degradation product of omeprazole. It has been reported to be an
antagonist for AHR in HepG2 cells [1] and it acts as an agonist for AHR in human
hepatocytes [2]. AHR is aryl hydrocarbon receptor, a mediated transactivation receptor-
type transcription factor. Omeprazole sulfide is also an important intermediate in phar-
maceuticals. It is usually used to synthesize omeprazole and esomeprazole, which are used
in the treatment of gastric acid related disorders [3–5] and are effective in the control of
gastric acidity of patients with Zollinger–Ellison syndrome, as well as in patients that do
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not respond well to histamine H2 receptor antagonists [3, 6]. In addition, gastrointestinal
(GI) diseases account for substantial morbidity, mortality, and cost [7], which leads to the
increased demand for the related drugs, such as omeprazole capsules, omeprazole enteric-
coated tablets, esomeprazole sodium for injection, and esomeprazole magnesium enteric-
coated tablets. It results in great demand for this key intermediate.
Omeprazole sulfide is synthesized using 2-mercapto-5-methoxybenzene imidazole and
2-chloromethyl-4-methoxy-3,5-lutidine [8] or 4-methoxy-3,5-dimethyl-2-pyridine-methyl
bromide [9] as substrate. It should be purified by dissolution, crystallization and separation.
Crystallization processes are the critical steps that determine the quality of the product [10]
of omeprazole sulfide to provide sufficient purity for the next reaction. So it is very
important to know the solubility of omeprazole sulfide as a function of temperature and
solvent composition in selected solvents required for the preparation and purification of the
products [11]. Moreover, no literature study has reported the correlation between the
solubility and temperature or the solvent composition. The most basic information for
solving the solvent selection problem is the basic physical properties and solubility data
[12]. Therefore we measured and correlated the solubility data of omeprazole sulfide in
different solvents (ethanol, 95 mass-% ethanol, ethyl acetate, isopropanol, methanol,
acetone, n-butanol and n-propanol) over the temperature range 280.35–319.65 K under
atmospheric pressure by the gravimetric method [13, 14]. Thus, systematic and necessary
information on the crystallization of omeprazole sulfide was obtained. For predicting the
solubility of a solute in different solvents, several methods have been presented [11, 15].
This study used the modified Apelblat equation and the Buchowski–Ksiazaczak kh
equation to correlate and predict the solubility of omeprazole sulfide in different solvents.
2 Experimental
2.1 Materials
A white crystalline powder of omeprazole sulfide was supplied by Shanghai Lingfeng
Chemical Reagent Co., China. The mass fraction was higher than 0.995, measured by high
performance liquid chromatography (HPLC type DIONEX P680 DIONEX Technologies).
Fig. 1 Chemical structure of
omeprazole sulfide
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The melting temperature was 392.15 K determined by differential scanning calorimeter
(Netzsch DSC 204). The ethanol, ethyl acetate, isopropanol, methanol, acetone, n-butanol
and n-propanol used for experiment were all analytical purity grade with mass fraction
purity higher than 0.995 except for 95 % ethanol. They were supplied by Shanghai Shenbo
Chemical Co., Ltd. and used without further purification.
2.2 Methods
The solubility of omeprazole sulfide was determined by a gravimetric method. The balance
used in these experiments was an analytical balance with an uncertainty of ±0.0001 g
(Sartorius, BS210S). 8 mL of solvent and a rotor were put into a 10 mL glass test tube with
stopper, and then excess omeprazole sulfide was added into the glass test tube [16]. The
test tubes were partly immersed in a constant-temperature bath. The temperature was
controlled by a jacketed vessel with water circulated through the outer jacket from a super
thermostatic water-circulator bath (type DC-2006 Ningbo XinYi Biotechnology Co., Ltd.).
Meanwhile, the inner chamber of the vessel needs a mercury-in-glass thermometer with an
uncertainty of ±0.05 K (calibrated by using a standard thermometer) for measuring the
solution equilibrium temperature. Continuous stirring was adopted for fully mixing the
suspension with a magnetic stirrer at each temperature [17].
In order to make sure that the solution system established the solid–liquid equilibrium, a
stirring time of 12 h was provided, and then the solution was kept still about 3 h to ensure a
dynamic balance was established between the dissolution and the crystallization processes.
Then, about 1 mL of supernatant was taken from the test tube and transferred to a pre-
viously weighed 5 mL sampling vial using a pre-warmed pipette [17, 18] carefully and
quickly. Subsequently, the mass of the sample was determined by weighing the sampling
vial again. Then the sampling vial was put into a dryer to dry at room temperature.
Afterwards the sampling vial was weighed on a regular basis until it reached a constant
weight. Each experiment was repeated at least twice to check the repeatability of the
solubility determination, and three samples were taken for each solvent at each temperature
[19] and the mean value was considered as the solubility. The saturated mole fraction
solubility (x) is obtained from the following equation:
x ¼ m1=M1
m1=M1 þ m2=M2 ð1Þ
where m1 represents the mass of solute and m2 the mass of solvents. M1 is the molecular
mass of solute and M2 that of the solvent.
3 Results and Discussion
3.1 Solubility Data and Correlation Models
The saturated mole fraction solubility (x) and the calculated solubility values (xc) of
omeprazole sulfide in ethanol, 95 % ethanol, ethyl acetate, isopropanol, methanol, acetone,
n-butanol and n-propanol in the temperature range from 280.35 to 319.65 K are presented
in Table 1.
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Table 1 The saturated mole fraction solubility (x) and the calculated solubility values (xc) by Eqs. 2 and 3
of omeprazole sulfide, in different solvents at the temperature range from 280.35 to 319.65 K
T/K x Equation 2 Equation 3
xc 100RD xc 100RD
Ethanol
280.35 0.0144 0.0148 -2.438 0.0142 1.507
284.35 0.0189 0.0193 -2.103 0.0189 0.264
288.15 0.0248 0.0247 0.415 0.0244 1.615
292.25 0.0323 0.0319 1.145 0.0318 1.490
296.65 0.0412 0.0417 -1.199 0.0418 -1.417
300.25 0.0511 0.0514 -0.734 0.0517 -1.183
303.15 0.0606 0.0606 -0.164 0.0610 -0.670
307.65 0.0775 0.0776 -0.145 0.0780 -0.569
311.15 0.0946 0.0934 1.269 0.0937 1.018
315.15 0.1151 0.1145 0.576 0.1145 0.571
319.65 0.1415 0.1424 -0.685 0.1420 -0.398
95 mass-% Ethanol
280.35 0.0101 0.0103 -1.912 0.0100 0.680
284.35 0.0137 0.0138 -0.882 0.0136 0.570
288.15 0.0178 0.0181 -1.881 0.0180 -1.194
292.25 0.0240 0.0240 -0.307 0.0240 -0.180
296.65 0.0325 0.0323 0.861 0.0323 0.673
300.25 0.0409 0.0407 0.503 0.0408 0.224
303.15 0.0489 0.0489 -0.043 0.0490 -0.315
307.65 0.0641 0.0643 -0.213 0.0644 -0.379
311.15 0.0791 0.0789 0.309 0.0789 0.259
315.15 0.0989 0.0989 -0.002 0.0988 0.053
319.65 0.1258 0.1260 -0.101 0.1259 -0.037
Ethyl acetate
280.35 0.0033 0.0032 2.293 0.0033 -0.852
284.35 0.0040 0.0040 2.238 0.0040 0.389
288.15 0.0049 0.0048 1.478 0.0048 0.561
292.25 0.0058 0.0059 -1.126 0.0059 -1.314
296.65 0.0073 0.0073 0.522 0.0072 0.839
300.25 0.0085 0.0086 -1.649 0.0086 -1.107
303.15 0.0098 0.0099 -0.273 0.0098 0.321
307.65 0.0122 0.0121 0.723 0.0120 1.233
311.15 0.0142 0.0142 0.586 0.0141 0.915
315.15 0.0165 0.0169 -2.217 0.0169 -2.192
319.65 0.0208 0.0206 1.074 0.0207 0.669
Isopropanol
280.35 0.0032 0.0033 -2.520 0.0031 2.624
284.35 0.0044 0.0045 -2.152 0.0043 1.309
288.15 0.0058 0.0059 -1.943 0.0058 0.218
292.25 0.0079 0.0080 -1.311 0.0079 -0.251
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Table 1 continued
T/K x Equation 2 Equation 3
xc 100RD xc 100RD
296.65 0.0108 0.0110 -1.907 0.0109 -1.683
300.25 0.0140 0.0141 -0.475 0.0141 -0.698
303.15 0.0172 0.0171 0.870 0.0172 0.439
307.65 0.0234 0.0230 1.764 0.0231 1.240
311.15 0.0286 0.0287 -0.405 0.0289 -0.842
315.15 0.0370 0.0369 0.363 0.0369 0.204
319.65 0.0482 0.0484 -0.361 0.0482 -0.039
Methanol
280.35 0.0127 0.0135 -5.842 0.0125 2.056
284.35 0.0178 0.0183 -2.814 0.0175 1.973
288.15 0.0239 0.0242 -1.458 0.0236 1.161
292.25 0.0322 0.0325 -0.975 0.0322 -0.012
296.65 0.0442 0.0440 0.444 0.0441 0.293
300.25 0.0559 0.0558 0.078 0.0562 -0.550
303.15 0.0668 0.0673 -0.629 0.0678 -1.411
307.65 0.0887 0.0888 -0.080 0.0894 -0.768
311.15 0.1103 0.1091 1.052 0.1096 0.627
315.15 0.1380 0.1367 0.974 0.1367 0.940
319.65 0.1721 0.1735 -0.862 0.1728 -0.446
Acetone
280.35 0.0050 0.0050 0.325 0.0051 -0.425
284.35 0.0065 0.0065 0.257 0.0066 -0.238
288.15 0.0083 0.0083 0.405 0.0083 0.108
292.25 0.0108 0.0107 0.908 0.0107 0.779
296.65 0.0140 0.0140 0.339 0.0140 0.337
300.25 0.0172 0.0172 -0.102 0.0172 -0.035
303.15 0.0203 0.0204 -1.543 0.0203 -1.444
307.65 0.0263 0.0262 0.335 0.0262 0.445
311.15 0.0319 0.0317 0.746 0.0317 0.832
315.15 0.0390 0.0392 -0.639 0.0392 -0.611
319.65 0.0496 0.0495 0.181 0.0495 0.103
n-Butanol
280.35 0.0103 0.0100 2.607 0.0102 0.882
284.35 0.0134 0.0131 1.640 0.0133 0.337
288.15 0.0171 0.0169 0.958 0.0171 0.045
292.25 0.0218 0.0220 -0.809 0.0221 -1.334
296.65 0.0292 0.0289 1.078 0.0289 0.928
300.25 0.0356 0.0359 -0.641 0.0358 -0.550
303.15 0.0425 0.0425 -0.140 0.0424 0.094
307.65 0.0549 0.0549 -0.054 0.0547 0.291
311.15 0.0661 0.0666 -0.655 0.0663 -0.334
315.15 0.0824 0.0823 0.061 0.0822 0.204
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The relationship between temperature and mole fraction solubility in different solvents
is described by the modified Apelblat equation, which is a semiempirical equation derived
from the Clausius–Clapeyron equation [20, 21], which is as follows:
ln x ¼ A þ B
T
þ C ln T ð2Þ
where T represents the absolute temperature, A, B and C are the model parameters, and x is
the mole fraction solubility of omeprazole sulfide. The constants A and B represent the
variation in the solution activity coefficient and provide an indication of the effect of non-
ideal solution behavior on the solute solubility, while the constant C reflects the temper-
ature influence on the enthalpy of fusion [22]. The adjustable parameters A, B and C can be
obtained by fitting the experimental solubility data.
The Buchowski–Ksiazaczak kh equation is an alternate way to describe solid–liquid
equilibrium behavior of omeprazole sulfide, as first proposed by Buchowski et al. [23]. The
experimental data for many systems can be well represented by the Buchowski–Ksiazaczak
kh equation with only two parameters k and h [24–27]. In this paper, the solubility data
were also correlated with the Buchowski–Ksiazaczak kh equation:









where T represents the system temperature, Tm is the melting point temperature of ome-
prazole sulfide in Kelvin, x is the mole fraction solubility of omeprazole sulfide and k and
h are the model parameters determined by the experimental data in the system.
Using the values in Table 1, the parameters of A, B and C were estimated and presented
in Table 2, and the parameters of k and h are listed in Table 3, together with the root-
mean-square deviations (RMSDs) and the relative average deviations (RADs).
Table 1 continued
T/K x Equation 2 Equation 3
xc 100RD xc 100RD
319.65 0.1039 0.1037 0.225 0.1039 -0.052
n-Propanol
280.35 0.0076 0.0077 -1.845 0.0076 -0.541
284.35 0.0101 0.0103 -1.479 0.0102 -0.767
288.15 0.0134 0.0134 -0.416 0.0134 -0.106
292.25 0.0178 0.0177 0.657 0.0177 0.690
296.65 0.0234 0.0236 -0.837 0.0236 -0.954
300.25 0.0296 0.0297 -0.158 0.0297 -0.310
303.15 0.0359 0.0355 1.109 0.0356 0.972
307.65 0.0470 0.0466 0.827 0.0466 0.755
311.15 0.0567 0.0571 -0.600 0.0571 -0.611
315.15 0.0713 0.0715 -0.361 0.0715 -0.323
319.65 0.0914 0.0913 0.154 0.0913 0.173
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The RMSD is defined as follows:
RMSD ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPN













where N is the number of experimental points obtained in each set, which equals the
number of temperatures used, xc represents the calculated solubility values and xe the
experimental solubilities.
The relative deviations (RDs) between the experimental values and the calculated





where xc represents the calculated solubilities and xe the experimental values.
The x/T curves of omeprazole sulfide, measured in all the solvents studied, are presented
in Fig. 2. As we can see from Fig. 2, all the solubility curves are similar, with low
solubilities at low temperature, which increase at higher temperatures [28]. The solubility
is a function of temperature and increases with increasing temperature. From Fig. 2, it can
Table 2 Parameters of Eq. 2 for mole fraction solubility of omeprazole sulfide in various solvents
Solvent A B C 102 RMSD 102 RAD
Ethanol 169.713 -12176.733 -23.160 1.082 0.973
95 % Ethanol 100.445 -9611.497 -12.564 0.521 0.408
Ethyl acetate -105.237 932.180 17.069 1.069 0.945
Isopropanol 121.765 -10949.042 -15.700 1.149 0.868
Methanol 290.941 -18217.582 -40.870 1.125 0.930
Acetone -0.480 -4587.603 2.051 0.627 0.487
n-Butanol 31.893 -6080.526 -2.624 0.610 0.459
n-Propanol 86.751 -8848.671 -10.657 0.632 0.564
Table 3 Parameters of Eq. 3 for mole fraction solubility of omeprazole sulfide in various solvents
Solvent k h 102 RMSD 102 RAD
Ethanol 3.582 1504.278 1.217 0.988
95 % Ethanol 4.097 1447.915 0.918 0.639
Ethyl acetate 0.202 20201.853 1.469 1.289
Isopropanol 1.770 3496.429 1.496 1.279
Methanol 7.224 853.657 2.100 1.382
Acetone 1.012 5153.445 0.659 0.525
n-Butanol 2.614 2091.202 1.093 0.806
n-Propanol 2.703 2129.557 0.922 0.767
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be seen that the solubility of omeprazole sulfide is relatively low in acetone, isopropanol
and ethyl acetate at all temperatures. The solubility in ethyl acetate has the smallest
percentage change, while the solubility in acetone is substantially the same as in isopro-
panol. As for the other five solvents, the solubilities are more sensitive to temperature,
especially methanol in which the solubility varies much more obviously with temperature,
ethanol and 95 % ethanol. So methanol, ethanol and 95 % ethanol can be used to
recrystallize omeprazole sulfide. However, in industrial production, taking the safety and
cost into account, ethanol or 95 % ethanol presents a potential advantage in the crystal-
lization process of omeprazole sulfide.
As we all know, methanol, ethanol, propanol and butanol are protic solvents that have a
hydrogen atom bound to an oxygen (in a hydroxyl group). The molecules of such solvents
can readily donate protons and interact with solute molecules by hydrogen bonding. The
hydrogen bonds could increase the solubility of the solute. This may be the reason that the
solubility is relatively high in methanol, ethanol, 95 % ethanol, n-butanol and n-propanol.
The solubility in methanol and ethanol is higher than that in n-propanol and n-butanol. This
phenomenon can be explained by the fact that when the alcohol chain length increases, the
hydrogen bonds with alcohols are weakened [29]. However, the solubility in isopropanol is
relatively low, perhaps because the hydroxy of the isopropanol molecules is located
between two CH3 groups, which hinder the interaction of the H and N atoms. The solu-
bility of omeprazole sulfide is lower in 95 % ethanol than in ethanol. The reason may be
that the sulfide compounds are practically insoluble in water.
As can be seen from Tables 1, 2 and 3, the calculated data of omeprazole sulfide in a
total of eight solvents show good agreement with the experimental data. For the modified
Apelblat equation, as we can see from Tables 1 and 2, the RADs are 0.97, 0.41, 0.95, 0.87,
0.93, 0.49, 0.46 and 0.56 %, respectively and the absolute values of RDs do not exceed
2.6 %, which indicates that all the solubility data can be calculated in the selected solvents
when the modified Apelblat equation is used. The same is true for analyzing the solubility
data and the parameters that fitted the kh equation. Furthermore, from Tables 2 and 3, all
the solubilities are calculated with reasonable RMSD and the average RMSDs are 0.85 and
1.2, for the modified Apelblat and Buchwski–Ksiazaczak kh equations respectively.
Therefore the regression result of the modified Apelblat equation is more accurate than the
Fig. 2 Solubilities of omeprazole sulfide in different solvents at atmospheric pressure. Left pointing filled
triangle methanol, filled square ethanol, filled triangle 95 % ethanol, open square n-butanol, inverted
triangle n-propanol, open circle acetone, right pointing filled triangle isopropanol, filled circle ethyl acetate.
Solid lines calculated using Eq. 2
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Buchowski–Ksiazaczak kh equation. Compared to the Buchowski–Ksiazaczak kh equa-
tion, the modified Apelblat equation is proposed for solid–liquid equilibria, and it is widely
accepted as being capable of dealing with solvent systems. Therefore, the measured sol-
ubility data and the correlation equation in this work can be applied to the design and
optimization for the extraction and purification process of omeprazole sulfide [19].
3.2 Thermodynamic Properties for the Solution
The temperature dependence of the solubility allows a thermodynamic analysis that per-
mits insight into the molecular mechanisms involved in the solution processes [30]. In this
study, the thermodynamic functions in the process of solution of omeprazole sulfide are
calculated on the basis of the solubility of omeprazole sulfide in different solvents. The
standard molar enthalpy of solution DHosoln
 
is accessible from this equation, which is the






where x1 is themole fraction solubility, R represents the universal gas constant (8.314 JK-1mol-1)
and T is the absolute temperature. The standard molar enthalpy change of solution, DHosoln, is
generally obtained from the slope of the solubility curve in a so-called van’t Hoff plot where
ln x is plotted against T-1. Over a limited temperature interval, the heat capacity change of a
solution may be assumed to be constant, hence the derived values of DHosoln will also be valid
for the mean temperature, Tmean = 300 K [33]. Equation 7 can also be written as:
DHosoln ¼ R
o ln x
o 1=T  1=Tmeanð Þ
 	
ð8Þ
The ln x versus (1/T - 1/Tmean) curves of omeprazole sulfide in the eight solvents are
shown in Fig. 3.
The standard molar Gibbs energy of solution DG0soln can be calculated according to [34]:
DGosoln ¼ RTmean  intercept ð9Þ
where the intercept used is that obtained in plots of lnx versus (1/T - 1/Tmean). The





The results of the standard Gibbs energy, enthalpy, and entropy of solution are shown in
Table 4, together with nH and nTS. The nH and nTS represent the comparison of the relative











 þ TDSosoln  100: ð12Þ
The conclusion can be drawn from Table 4 that the enthalpy and the standard Gibbs
energy of solution of omeprazole sulfide are positive in the eight solvents, indicating the
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solution process of omeprazole sulfide in a total of eight solvents is endothermic. More-
over, the main contributor to the standard molar Gibbs energy of solution is the enthalpy
during the dissolution, because the values of % nH are C54 %.
4 Conclusions
The solubility of omeprazole sulfide in a total of eight solvents has been measured from
280.35 to 319.65 K by a dependable experimental method and simple solubility apparatus.
For all solvents, solubility is a function of temperature and increases with increasing
temperature, but to each increment of temperature they responded with a definite change of
solubility. The experimental data were fitted by using the modified Apelblat equation and
Fig. 3 Mole fraction solubility (ln x) of omeprazole sulfide in different solvents against 104 (1/T - 1/Tmean)
with a straight line to correlate the data. Left pointing filled triangle methanol, filled square ethanol, filled
circle 95 % ethanol, diamond n-butanol, open square n-propanol, right pointing filled triangle acetone,
inverted triangle isopropanol, filled triangle ethyl acetate
Table 4 Thermodynamic functions relative to solution process of omeprazole sulfide in solvents at mean
temperature
DHosoln (kJmol-1) DGosoln (kJmol-1) DSosoln (JK-1mol-1) %nH %nTS
Ethanol 43.401 7.483 119.770 54.717 45.283
95 % Ethanol 48.085 8.191 133.031 54.655 45.345
Ethyl acetate 34.744 11.876 76.255 60.307 39.693
Isopropanol 51.695 10.718 136.640 55.783 44.217
Methanol 49.457 7.315 140.528 53.993 46.007
Acetone 43.286 10.170 110.427 56.656 43.344
n-Butanol 43.956 8.357 118.708 55.252 44.748
n-Propanol 47.175 8.846 127.811 55.173 44.827
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kh equations and the Apelblat equation is more accurate than the kh equation for this
system. The calculated solubility of omeprazole sulfide shows good agreement with the
experimental values, and experimental solubility data from this work can be used for
designing a purification process of omeprazole sulfide. The thermodynamic properties for
the solution process including Gibbs energy, enthalpy, and entropy were obtained by the
van’t Hoff analysis. The thermodynamic parameters values show that the solution process
of omeprazole sulfide in a total of eight solvents is endothermic and the larger contributor
to the standard molar Gibbs energy of solution is the enthalpy change during the
dissolution.
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